Propranolol treatment for chylothorax due to diffuse lymphangiomatosis
| dc.contributor.author | HANGÜL MELİH | |
| dc.contributor.author | KÖSE MEHMET | |
| dc.contributor.author | ÖZCAN ALPER | |
| dc.contributor.author | ÜNAL EKREM | |
| dc.contributor.author | Ünal, Ekrem | |
| dc.date.accessioned | 2026-06-12T11:49:07Z | |
| dc.date.issued | 2019 | |
| dc.description | SCI-Expanded | YÖK-Özgeçmiş | |
| dc.identifier.doi | 10.1002/pbc.27592 | |
| dc.identifier.issn | 1545-5017 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.11782/5922 | |
| dc.relation.ispartof | Pediatric Blood & Cancer | |
| dc.title | Propranolol treatment for chylothorax due to diffuse lymphangiomatosis | |
| dspace.entity.type | Publication | |
| relation.isAuthorOfPublication | cd35ec05-b9b3-4f63-a13f-bc9dc6344971 | |
| relation.isAuthorOfPublication.latestForDiscovery | cd35ec05-b9b3-4f63-a13f-bc9dc6344971 |